The program is focused initially on eight cancers: melanoma, lung, prostate, breast and ovarian as well as chronic lymphocytic leukemia (CLL), myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML).MD Anderson employs more than 20,000 people, including more than 1,600 faculty.